{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:20:20Z","timestamp":1781137220524,"version":"3.54.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.cpcardiol.2020.100747","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T12:02:18Z","timestamp":1604577738000},"page":"100747","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Portopulmonary Hypertension: Prevalence, Clinical and Hemodynamic Features"],"prefix":"10.1016","volume":"46","author":[{"given":"Dulce Iliana","family":"Navarro-Vergara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Roldan-Valadez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Cueto-Robledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merly Yamile","family":"Jurado-Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpcardiol.2020.100747_bib0001","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1183\/09059180.00007211","article-title":"Portopulmonary hypertension and hepatopulmonary syndrome: a clinician-oriented overview","volume":"21","author":"Porres-Aguilar","year":"2012","journal-title":"European Respiratory Review"},{"key":"10.1016\/j.cpcardiol.2020.100747_bib0002","doi-asserted-by":"crossref","first-page":"8072","DOI":"10.3748\/wjg.v20.i25.8072","article-title":"Portopulmonary hypertension and hepatopulmonary syndrome","volume":"7","author":"Aldenkortt","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cpcardiol.2020.100747_bib0003","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1097\/TP.0000000000001666","article-title":"Predictors of waitlist mortality in portopulmonary hypertension","volume":"101","author":"DuBrock","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.cpcardiol.2020.100747_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/TXD.0000000000000900","article-title":"Portopulmonary hypertension: a survey of practice patterns and provider attitudes","volume":"5","author":"DuBrock","year":"2019","journal-title":"Transplant Direct"},{"key":"10.1016\/j.cpcardiol.2020.100747_bib0005","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1136\/gut.52.9.1355","article-title":"Portopulmonary hypertension in decompensated cirrhosis with refractory ascites","volume":"52","author":"Benjaminov","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.cpcardiol.2020.100747_bib0006","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/lt.500030503","article-title":"Severe pulmonary hypertension in liver transplant candidates","volume":"3","author":"Ramsay","year":"1997","journal-title":"Liver Transpl Surg"},{"key":"10.1016\/j.cpcardiol.2020.100747_bib0007","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1378\/chest.11-0160","article-title":"Portopulmonary hypertension: a report from the US-based REVEAL Registry","volume":"141","author":"Krowka","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.cpcardiol.2020.100747_bib0008","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1378\/chest.09-1140","article-title":"Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry","volume":"137","author":"Badesch","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.cpcardiol.2020.100747_bib0009","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/hep.22275","article-title":"Clinical risk factors for portopulmonary hypertension","volume":"48","author":"Kawut","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cpcardiol.2020.100747_bib0010","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00740-2017","article-title":"Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model","volume":"50","author":"Hoeper","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cpcardiol.2020.100747_bib0011","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cpcardiol.2020.100747_bib0012","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1183\/09031936.04.00010904","article-title":"Pulmonary-hepatic vascular disorders (PHD)","volume":"24","author":"Rodriguez-Roisin","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cpcardiol.2020.100747_bib0013","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1164\/rccm.200804-613OC","article-title":"Portopulmonary hypertension: survival and prognostic factors","volume":"178","author":"Le Pavec","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cpcardiol.2020.100747_bib0014","doi-asserted-by":"crossref","unstructured":"Martin P, DiMartini A, Feng S, Brown RJ, Fallon M. Evaluation for liver transplantation in adults: 2013 Practice guideline by the AASLD and the American Society of Transplantation. Am Assoc SudyLiver Dis. 2013:1-98.","DOI":"10.1002\/hep.26972"},{"key":"10.1016\/j.cpcardiol.2020.100747_bib0015","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","article-title":"2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS)","volume":"37","author":"Galie","year":"2016","journal-title":"Eur Heart J."},{"key":"10.1016\/j.cpcardiol.2020.100747_bib0016","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1586\/17474124.2015.1035647","article-title":"What's new in the treatment of portopulmonary hypertension?","volume":"9","author":"DuBrock","year":"2015","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cpcardiol.2020.100747_bib0017","doi-asserted-by":"crossref","first-page":"46","DOI":"10.29245\/2572-9411\/2017\/4.1111","article-title":"Portopulmonar hypertension: Is there something new?","volume":"2","author":"Toapanta-Yanchapaxi","year":"2017","journal-title":"J Rare Dis Res Treatment"},{"key":"10.1016\/j.cpcardiol.2020.100747_bib0018","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.cld.2006.08.005","article-title":"Measurement of portal pressure: when, how, and why to do it","volume":"10","author":"Groszmann","year":"2006","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cpcardiol.2020.100747_bib0019","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1111\/ajt.12783","article-title":"MELD exceptions for portopulmonary hypertension: current policy and future implementation","volume":"14","author":"Goldberg","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cpcardiol.2020.100747_bib0020","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1093\/eurheartj\/ehx257","article-title":"A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension","volume":"39","author":"Kylhammar","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2020.100747_bib0021","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/MCP.0000000000000510","article-title":"Risk stratification in pulmonary arterial hypertension","volume":"24","author":"Weatherald","year":"2018","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.cpcardiol.2020.100747_bib0022","first-page":"25","article-title":"Hipertensi\u00f3n portopulmonar: revisi\u00f3n actualizada","volume":"88","author":"Rodr\u00edguez-Almendros","year":"2018","journal-title":"Arch Cardiol Mex"},{"key":"10.1016\/j.cpcardiol.2020.100747_bib0023","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.3748\/wjg.v22.i6.2024","article-title":"Portopulmonary hypertension in liver transplant candidates","volume":"14","author":"Bozbas","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cpcardiol.2020.100747_bib0024","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1209655","article-title":"Riociguat for the treatment of pulmonary arterial hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2020.100747_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2045894018769305","article-title":"Riociguat treatment for portopulmonary hypertension: a subgroup analysis from the PATENT-1\/-2 studies","volume":"8","author":"Cartin-Ceba","year":"2018","journal-title":"Pulm Circ"},{"key":"10.1016\/j.cpcardiol.2020.100747_bib0026","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S2213-2600(19)30091-8","article-title":"Macitentan for the treatment of portopulmonary hypertension (PORTICO): a multicentre, randomised, double-blind, placebo-controlled, phase 4 trial","volume":"7","author":"Sitbon","year":"2019","journal-title":"Lancet Respir Med"}],"updated-by":[{"DOI":"10.1016\/j.cpcardiol.2021.100955","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000}}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280620302231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280620302231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,30]],"date-time":"2021-10-30T08:53:42Z","timestamp":1635584022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280620302231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0146280620302231"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2020.100747","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Portopulmonary Hypertension: Prevalence, Clinical and Hemodynamic Features","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2020.100747","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}],"article-number":"100747"}}